Who should consider taking this test?
Anyone who is interested in learning about their inherited risks for cancer can take the test. The likelihood of testing positive is higher for those with a personal and/or family history of cancer, as well as those with Ashkenazi Jewish ancestry.The panel offered through jscreen is designed for individuals of all ancestries and includes hereditary cancer risks found in people of all different backgrounds.
How long will it take to get results?
Test results are provided in an easy to understand report available within 3 weeks of the sample arriving at the lab. You will have an opportunity to discuss your results with a genetic counselor.
Will genetic testing be covered by my insurance?
95% of private insurance companies have coverage for hereditary cancer testing.
Through insurance coverage and financial assistance, for those who meet criteria for testing, 90% of tested customers pay $0 out-of-pocket.
Based on internal Myriad data, 2023
Who should consider taking this test
The Reproductive Carrier Screen is intended for people who are planning to start or expand their family and wish to know if they are at an increased risk of having a child with a genetic condition.
How long will it take to get results?
Test results are provided in an easy to understand report available within 3 weeks of the sample arriving at the lab. You will have an opportunity to discuss your results with a genetic counselor.
Will genetic testing be covered by my insurance?
Your cost for screening depends on several factors, including your insurance plan and any copay or unmet deductible. More than 80% of individuals pay $0 out-of-pocket because their insurance companies cover carrier screening.
Once the lab receives your kit, you will be sent a personalized cost estimate letting you know what your insurance is likely to cover, what your additional out-of-pocket costs are expected to be, and what your options are.
If your insurance does not pay for testing, you do not meet your policy’s guidelines for testing, you are uninsured, or you have a high unmet deductible, you can forgo insurance and directly pay a self-pay price of $249 for your carrier screen. If you cannot afford testing, there are financial assistance programs available for those who qualify.
Clear cost estimates from our lab partner
1. Self-pay: $49 due now. (and $249 will be billed to you from our lab partner). Nothing is billed to insurance. A customer service representative from our partner, Myriad, will call you to collect credit card payment after you ship your kit back with the prepaid shipping label.
2. Insurance: $49 due now, the rest is billed to your insurance. If you select to pay for your test through insurance, a few days after our lab partner, Myriad, receives your saliva sample, they will contact you via email and/or text to let you know your cost estimate.
Your estimate will consider:
- Your insurance plan
- How much of your deductible has been paid so far this year
- Any copays or coinsurance per your plan
- Eligibility for financial assistance
You will receive an email/text from Myriad notifying you that your estimate is ready to view. Most people will pay $0, but if your estimate shows you’ll have an out-of-pocket cost you have options.
Contact Myriad right away to:
If Myriad does not hear from you before your test results are reported, which is usually 7-14 days after Myriad receives your sample, Myriad will file a claim with your health insurance company. Your insurer may send you an Explanation of Benefits (EOB), but this is not a bill.
For billing questions, please contact Myriad or jscreen:
Myriad customer service: 800-469-7423 / cscomments@myriad.com [8am - 8pm ET]
Myriad billing: 844-697-4239 / billinghelp@myriad.com
Myriad Billing Live chat: https://myriad.com/billingchat/ [8am - 8pm ET]
jscreen: hello@jscreen.org
Clear cost estimates from our lab partner
1. Self-pay: $49 due now. (and $249 will be billed to you from our lab partner). Nothing is billed to insurance. A customer service representative from our partner, Myriad, will call you to collect credit card payment after you ship your kit back with the prepaid shipping label.
2. Insurance: $49 due now, the rest is billed to your insurance. If you select to pay for your test through insurance, a few days after our lab partner, Myriad, receives your saliva sample, they will contact you via email and/or text to let you know your cost estimate.
Your estimate will consider:
- Your insurance plan
- How much of your deductible has been paid so far this year
- Any copays or coinsurance per your plan
- Eligibility for financial assistance
You will receive an email/text from Myriad notifying you that your estimate is ready to view. Most people will pay $0, but if your estimate shows you’ll have an out-of-pocket cost you have options.
Contact Myriad right away to:
If Myriad does not hear from you before your test results are reported, which is usually 7-14 days after Myriad receives your sample, Myriad will file a claim with your health insurance company. Your insurer may send you an Explanation of Benefits (EOB), but this is not a bill.
For billing questions, please contact Myriad or jscreen:
Myriad customer service: 800-469-7423 / cscomments@myriad.com [8am - 8pm ET]
Myriad billing: 844-697-4239 / billinghelp@myriad.com
Myriad Billing Live chat: https://myriad.com/billingchat/ [8am - 8pm ET]
jscreen: hello@jscreen.org
And receive your kit by mail.
Collect your saliva sample from the comfort of your home.
Receive your results within 3 weeks after mailing the kit with the prepaid shipping label.
Schedule your virtual genetic counseling session.
.jpg)
Actionable
The hereditary cancer test includes an easy to understand report with actionable results that will inform a personalized care plan. The test evaluates 48 genes to help identify the risk of 11 different types of hereditary cancer, including breast, colon, and pancreatic cancer.
Affordable
We are committed to providing you with access to reliable and affordable genetic testing. Cancer genetic testing is covered by most insurance plans, for those who meet certain criteria, and our lab partner offers the option of affordable cash pay prices and financial assistance programs for those who qualify.
Peace of mind
In addition to providing results for the 48 genes tested, a genetic counseling session, a personalized care plan, and a breast cancer risk score for eligible individuals is provided. After your genetic counseling appointment, you will have a clear understanding of your results, an assessment of your risks, and a well-defined plan for your next step.
Actionable
Test results are provided in an easy to understand report available within 3 weeks of the sample arriving at the lab. If an individual or couple learns that they or their future children are at risk for a genetic disease, a genetic counselor will provide options for family planning or medical care.
Affordable
Jscreen is committed to helping you access reliable and affordable genetic testing. Carrier testing is covered by most insurance plans and our lab partner offers the option of affordable cash pay prices and financial assistance programs for those who
Peace of Mind
If an action plan is needed, a care navigator will work with you on a plan that fits your needs. You can feel confident knowing that the carrier screen offered through the Jscreen program, is the only validated carrier screening panel in the US backed by 20+ peer-reviewed publications and >1.6M patients screened.
Hereditary Cancer Screening
Find answers to commonly asked questions about our genetic testing and services.
What is the hereditary cancer panel?
Jscreen provides access to a cancer genetic testing panel that looks for mutations (or genetic changes) in 48 genes, such as BRCA1 and BRCA2, that are related to hereditary cancer. Each cancer gene on the panel is associated with specific cancer types and varying degrees of risk. To view a complete list of genes on the panel, click here.
Why should I consider doing hereditary cancer genetic testing?
You should consider testing if you want to learn as much as you can about your risk of cancer. Anyone who has a personal or family history of cancer may be at increased risk and should consider testing. Knowing your risk will help inform your healthcare choices.
If I have a mutation, will my children have it too?
Each child (son or daughter) of a man or woman with a cancer gene mutation has a 50% chance of inheriting the mutation. Your genetic counselor can discuss the right time to test your children, as well as options for individuals who are planning to expand their families.
Is all cancer hereditary?
No. There are many factors that contribute to a person’s risk for developing cancer, including lifestyle, diet, environmental exposures, and chance. But some cancers are related to specific genetic changes that are inherited. For example, about 5-10% of breast cancers and about 20-25% of ovarian cancers are due to inherited genetic changes. A person may have an inherited change in a cancer gene even if cancer hasn’t occurred in their family. If you have specific questions related to your personal or family history of cancer, please contact a jscreen genetic counselor at genetic.counselor@jscreen.org.
What is genetic cancer testing?
Hereditary Cancer screening is a test to determine if an individual has an inherited genetic change that makes them more likely to develop cancer. This test analyzes 48 cancer-predisposition genes (including BRCA1 and BRCA2). If there is a harmful mutation in one or more of these genes, it will increase the risk for cancer. Each cancer gene on the panel is associated with specific cancer types and varying degrees of risk. In many cases, individuals who test positive have options to work with their healthcare providers to reduce the chances of developing cancer or to detect it at an early, treatable stage. Because we share genetic information with our biological family members, a positive result may also alert other relatives to consider testing. For those who have had a cancer diagnosis, knowing the genetic cause may help their doctors adjust their medical management and identify other cancer risks. This test does not screen for or diagnose cancer.
